BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7751099)

  • 1. Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo.
    Khalid M; Mujtaba G; Haroon TS
    Int J Dermatol; 1995 Mar; 34(3):203-5. PubMed ID: 7751099
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of segmental vitiligo to 0.05% clobetasol propionate cream.
    Khalid M; Mujtaba G
    Int J Dermatol; 1998 Sep; 37(9):705-8. PubMed ID: 9762827
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo.
    Camacho F; Mazuecos J
    J Drugs Dermatol; 2002 Sep; 1(2):127-31. PubMed ID: 12847735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized vitiligo successfully treated with cream-psoralen + ultraviolet A.
    Kreuter A; Gambichler T; Avermaete A; Jansen T; Altmeyer P; von Kobyletzki G
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):357-8. PubMed ID: 11730053
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
    Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
    Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of localized vitiligo with ulobetasol cream.
    Liu XQ; Shao CG; Jin PY; Wang HQ; Ye GY; Yawalkar S
    Int J Dermatol; 1990 May; 29(4):295-7. PubMed ID: 2370121
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
    Coskun B; Saral Y; Turgut D
    Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind trial of 0-05% clobetasol proprionate in the treatment of vitiligo.
    Clayton R
    Br J Dermatol; 1977 Jan; 96(1):71-3. PubMed ID: 320996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo treated with topical clobetasol propionate.
    Kumari J
    Arch Dermatol; 1984 May; 120(5):631-5. PubMed ID: 6721525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of vitiligo].
    Frenk E
    Hautarzt; 1986 Jan; 37(1):1-5. PubMed ID: 3949507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical trial of clobetasol propionate in Filipino vitiligo patients.
    Geraldez CB; Gutierrez GT
    Clin Ther; 1987; 9(5):474-82. PubMed ID: 3311364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukoderma punctata following topical PUVAsol treatment.
    Fernandes NC; Pina JC
    An Bras Dermatol; 2010; 85(4):571-2. PubMed ID: 20944925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of vitiligo with oral 5-methoxypsoralen.
    Hann SK; Cho MY; Im S; Park YK
    J Dermatol; 1991 Jun; 18(6):324-9. PubMed ID: 1939861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two diluents of 1% methoxsalen in the treatment of vitiligo.
    Godse KV
    Indian J Dermatol Venereol Leprol; 2008; 74(3):298. PubMed ID: 18597981
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis.
    Khandpur S; Sharma VK
    Clin Exp Dermatol; 2011 Aug; 36(6):613-6. PubMed ID: 21507036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.
    Decroix J; Pres H; Tsankov N; Poncet M; Arsonnaud S
    Cutis; 2004 Sep; 74(3):201-6. PubMed ID: 15499763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo.
    Halder RM; Battle EF; Smith EM
    Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo.
    Ho N; Pope E; Weinstein M; Greenberg S; Webster C; Krafchik BR
    Br J Dermatol; 2011 Sep; 165(3):626-32. PubMed ID: 21457214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream.
    Dalziel KL; Millard PR; Wojnarowska F
    Br J Dermatol; 1991 May; 124(5):461-4. PubMed ID: 2039723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halobetasol propionate cream by day and halobetasol propionate ointment at night for the treatment of pediatric patients with chronic, localized plaque psoriasis and atopic dermatitis.
    Herz G; Blum G; Yawalkar S
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1166-9. PubMed ID: 1757611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.